MyAverix Finance
KO · Healthcare
Hanall Biopharma (009420)
Drug Manufacturers - Specialty & Generic
Hanall Biopharma (009420) is listed on KO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 009420
Hanall Biopharma (009420) — FAQ
What is 009420's P/E ratio?
The price-to-earnings (P/E) ratio for Hanall Biopharma (009420) is 18.00 (data as of 2026-05-24).
Does Hanall Biopharma pay a dividend?
Dividend yield is not available in the current snapshot for Hanall Biopharma (009420). Check the MyAverix Finance app for the latest dividend data.
What sector is Hanall Biopharma in?
Hanall Biopharma (009420) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 009420 listed on?
009420 is listed on KO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.